InMed Pharmaceuticals Inc. (TSX:IN) (OTC:IMLFF) (FRA:MWG2) is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary bioinformatics database drug/disease targeting tool, cannabinoid biosynthesis technology, and drug development pipeline are the fundamental drivers of shareholder value.
Directions to listing
Send Message to listing owner
Listing Title: InMed Pharmaceuticals Inc.